CD10+ cell population in the bone marrow of patients with advanced neuroblastoma
- 1 January 1994
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 22 (2) , 115-118
- https://doi.org/10.1002/mpo.2950220210
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in NeuroblastomaNew England Journal of Medicine, 1991
- Bone Marrow Cell Populations Mimicking Common Acute Lymphoblastic Leukemia in Infants with Stage IV-S NeuroblastomaActa Haematologica, 1991
- Prognostic factors in Neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosisCancer, 1988
- Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.Journal of Clinical Oncology, 1984
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984
- USE OF PANELS OF MONOCLONAL ANTIBODIES IN THE DIFFERENTIAL DIAGNOSIS OF NEUROBLASTOMA AND LYMPHOBLASTIC DISORDERSThe Lancet, 1983
- Acute lymphoblastic leukaemia associated antigen. IV Expression on non-leukaemic ‘lymphoid’ cellsLeukemia Research, 1980
- Multiagent chemotherapy for children with metastatic neuroblastoma: A report from childrens cancer study groupMedical and Pediatric Oncology, 1979
- Neuroblastoma, Its Natural History and Prognosis: A Study of 487 CasesBMJ, 1974
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971